Press Releases

CHICAGO, Nov. 1, 2019 /PRNewswire/ -- In an effort to warn unsuspecting consumers about the growing problem of fraudulent, illicit clinics performing hair restoration surgery, the International Society of Hair Restoration Surgery (ISHRS) is launching a multi-pronged public awareness campaign to educate potential patients with tips and tools to find qualified hair re

MADISON, Wis., Nov. 1, 2019 /PRNewswire/ -- Prevagen has been recognized by Better Nutrition Magazine in its annual "Best of Supplements" awards in the category of

LLEIDA, Spain, Nov. 1, 2019 /PRNewswire/ -- The two-day event offers swine producers and other stakeholders essential, actionable information on developing profitable swine operations while reducing the use of antibiotics. "This is a very useful opportunity to learn from the experts, as well as from each other," says Michael Gerrits, Managi

NORTH CHICAGO, Ill., Nov. 1, 2019 /PRNewswire/ -- AbbVie (NYSE:ABBV) announced financial results for the third quarter ended September 30, 2019."Strong performance from our Immunology and Hematologic Oncology portfolios led our growth this quarter. We are also making excellent progress with several key strategic priorities, including the recent launch of our two new immunology therapies

MILWAUKEE, Nov. 1, 2019 /PRNewswire/ -- Promentis Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing innovative therapies for neuropsychia

MONMOUTH JUNCTION, N.J., Nov. 1, 2019 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in blood purification therapies to treat life-threatening conditions, anno

GERMANTOWN, Md., Nov. 1, 2019 /PRNewswire/ -- Seneca Biopharma, Inc., (NASDAQ: SCNA), a clinical-stage biopharmaceutical company developing novel treatments for diseases of unmet medical need, and Jiangsu QYuns Therapeutics Co., Ltd., a China-based company focused on monoclonal antibody therapeutics, jointly announce development plan

ST. LOUIS, Nov. 1, 2019 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("Centene") announced today the commencement, in connection with its previously announced acquisition of WellCare Health Plans, Inc. (NYSE:WCG) ("WellCare"), of exchange offers for any and all outstanding notes set forth in the table below (the "WellCare Notes") issued by WellCare for up to

CHICAGO, Nov. 1, 2019 /PRNewswire/ -- Hillrom (NYSE: HRC) today announced financial results for its fiscal fourth quarter and full year ended September 30, 2019. In addition, Hillrom provided its fiscal 2020 guidance and long-range financial outlook through fiscal 2022.

BRAINTREE, Mass., Nov. 1, 2019 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its second quarter and first half of fiscal 2020, which ended Sept. 28, 2019, are available on its Investor Relations website.